SI
SI
discoversearch

Biotech / Medical
Arbutus Biopharma
An SI Board Since February 2014
Posts SubjectMarks Bans Symbol
42 10 0 ABUS
Emcee:  donpat Type:  Moderated
Arbutus Biopharma Corporation is a biopharmaceutical company dedicated to discovering, developing and commercializing a cure for patients suffering from chronic HBV infection. Arbutus is headquartered in Vancouver, BC, and has facilities in Warminster, PA. For more information, visit
arbutusbio.com
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
42_____________________ FORM 8-K _____________________ CURRENT REPORT Pursuant donpat-September 22
41investor.arbutusbio.comdonpat-12/12/2016
40Tekmira renamed Arbutus Biopharma Corporation (ABUS).donpat-8/3/2015
39Tekmira Pharmaceuticals Receives $28.75 Average PT from Analysts (NASDAQ:TKMR) donpat-5/7/2015
38Combatting Viruses with RNA-Targeted CRISPRScientists re-engineer a Cas9 enzyme donpat14/27/2015
37Cancer Drug Shows Promise for Treating Hepatitis B Mon, 04/20/2015 - 4:46pm Wadonpat14/21/2015
36Tekmira Pharmaceuticals Corp Price Target Update by Thomas Lindt on March 4, 20donpat-3/4/2015
35Gilead ( GILD) Agrees to a Discounted Price of $46,000 for Sovaldi in Europe 2donpat-2/13/2015
34Reasons for the Merger In evaluating the merger and the Merger Agreement, thdonpat-1/24/2015
33It was revealed in a filing yesterday with the U.S Securities and Exchange Commdonpat-1/21/2015
32The Company continues to see evidence of anti-tumor activity in some treated subdonpat-12/31/2014
31 Multifunctional RNA nanoparticles to combat cancer and viral infections Postedonpat-10/13/2014
30MARKET REPORT: Merger mania in healthcare sector keeps dealers on toes during pedonpat-8/27/2014
29Ebola declared a public-health emergency World Health Organization announcemendonpat-8/8/2014
28FDA switches course on Tekmira drug as Ebola panic triggers policy review [gradonpat-8/8/2014
27FDA Modifies Tekmira's TKM-Ebola Clinical Hold to Partial Hold PRESS RELEASdonpat-8/7/2014
26FDA Greenlights Use of TKM-EBOLA in Current Outbreak Thursday, August 7, 2014 donpat-8/7/2014
25Tekmira Pharmaceuticals Corp (TKMR) After Hours Trading TKMR $15.43 +1.16 +8.13donpat-8/7/2014
24Ebola Drug by Tekmira May Be Used on Infected Patients By Cynthia Koons, Caroldonpat-8/7/2014
23Human Ebola Virus Species and Compositions and Methods Thereof US 20120251502 Ascion-8/2/2014
22U.S. FDA says 'stands ready' to work with companies developing Ebola drudonpat-8/2/2014
21Ebola Experimental Treatments: Tekmira TKM-EBOLA, Mapp Biopharmaceuticals MB-003donpat-8/2/2014
20Tekmira shares skyrocket as Ebola outbreak intensifies in Africa Fri Aug 1, 20donpat-8/1/2014
19 Tekmira Pharmaceuticals Now Covered by Clarus (TKMR) Posted by Seth Barnet on donpat-8/1/2014
18Ebola Virus Now Threatens 21 Million People In Major Metro Area Published on Judonpat-7/29/2014
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
Copyright © 1995-2017 Knight Sac Media. All rights reserved.Stock quotes are delayed at least 15 minutes - See Terms of Use.